On the 1st January 2019, the South China Post[1]published a story on Vitasoy International Holdings (Vitasoy 0345.HK) entitled “Cooler than Marijuana”.[2] Whilst this related to the huge internet memes[3] following of Vitasoy’s lemon tea in China, it could also be applied to the stock price performance, and high valuation multiple:
With Vitasoy’s lack of research coverage by mainstream houses, the fact that they are due to report their fiscal 2019 March year-end earnings on 20th June 2019, and an expectation of slower growth ahead, our initial bias is one of negativity. In this report, we examine whether the stock warrants the multiple awarded to it by the market.
However, with Vitasoy entering the Hong Kong MSCI Index in May, we ask - when is the right time to purchase a stock, with a solid fundamental case and earnings influenced by China’s burgeoning consumer base.
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.